Total cash vs. overseas cash of select us biopharma companies Q3 2017
This statistic shows the total cash vs. overseas cash balances of select top U.S. pharmaceutical companies as of third quarter (Q3) in 2017 outside. In that period, the total cash of Amgen Inc. was 41 billion U.S. dollars of which 39 billion dollars were held outside the United States.